ArticleOncoimmunology2015

BTLA marks a less-differentiated tumor-infiltrating lymphocyte subset in melanoma with enhanced survival properties.

Cara L Haymaker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.